Therapeutic application of caspase 1/interleukin-1beta-converting enzyme inhibitor decreases the death rate in severe acute experimental pancreatitis - Wikidata - wikimedia - TriplyDB

Therapeutic application of caspase 1/interleukin-1beta-converting enzyme inhibitor decreases the death rate in severe acute experimental pancreatitis

Therapeutic application of caspase 1/interleukin-1beta-converting enzyme inhibitor decreases the death rate in severe acute experimental pancreatitis

http://www.wikidata.org/entity/Q28344080

about

Sterile inflammatory response in acute pancreatitis Immunomodulatory therapies for acute pancreatitis.Epidural anaesthesia restores pancreatic microcirculation and decreases the severity of acute pancreatitis.Preparation method of an ideal model of multiple organ injury of rat with severe acute pancreatitis.Caspase inhibitors attenuate superantigen-induced inflammatory cytokines, chemokines, and T-cell proliferation.Inhibition of the nucleotide-binding domain, leucine-rich containing family, pyrin-domain containing 3 inflammasome reduces the severity of experimentally induced acute pancreatitis in obese mice.Caspase-1 is hepatoprotective during trauma and hemorrhagic shock by reducing liver injury and inflammation Panhematin provides a therapeutic benefit in experimental pancreatitis.Roles of caspase 1 and extracellular signal-regulated kinase in inflammation-induced inhibition of lacrimal gland protein secretion.Interleukin-18: a pro-inflammatory cytokine that plays an important role in acute pancreatitis.Paeoniflorin ameliorates acute necrotizing pancreatitis and pancreatitis‑induced acute renal injury Immunomodulation in surgical practice.Use of gene expression profiles in cells of peripheral blood to identify new molecular markers of acute pancreatitis.Rosiglitazone attenuates the severity of hyperlipidemic severe acute pancreatitis in rats.Necro-inflammatory response of pancreatic acinar cells in the pathogenesis of acute alcoholic pancreatitis.Infusion of Bone Marrow Mesenchymal Stem Cells Attenuates Experimental Severe Acute Pancreatitis in Rats.Pathogenic mechanisms of pancreatitis.Current status of inflammasome blockers as anti-inflammatory drugs.The role of inflammasome-derived IL-1 in driving IL-17 responses.Immune-modulating therapy in acute pancreatitis: fact or fiction.Hepatitis regulation by the inflammasome signaling pathway.Circulating nucleosomes as predictive markers of severe acute pancreatitis.The clinical course of acute pancreatitis and the inflammatory mediators that drive it.Therapeutic effects of caspase-1 inhibitors on acute lung injury in experimental severe acute pancreatitis Caspase-1 inhibition alleviates acute renal injury in rats with severe acute pancreatitis Zerumbone attenuates the severity of acute necrotizing pancreatitis and pancreatitis-induced hepatic injury.Therapeutic effects of electroacupuncture at ST36 acupoint on sodium-taurocholate-induced severe acute pancreatitis.Caspase-1 activation is increased with human labour in foetal membranes and myometrium and mediates infection-induced interleukin-1β secretion.Hypothermia induced by adenosine 5'-monophosphate attenuates injury in an L-arginine-induced acute pancreatitis rat model.

P2860

Q27023854-8362EBBB-9047-46F8-B3C3-A1558D1A2AB8 Q27691380-7C78A5D3-CA84-4784-AE82-5ADDC4C07394 Q33235669-DA9EABE0-2DAB-459E-90E3-514E7C2E7A7A Q33295511-2F8F046A-7C0D-443D-8E43-6D50C58097C6 Q33712106-F3B510F4-8E2F-4E91-B053-198E6E1EA6EB Q34270508-EF5882BA-A9FA-484C-8370-02D4B7C25BC2 Q35286840-DD9ED73E-AA05-408D-86E5-2A9AC063352C Q36634619-4ED6B774-9121-421B-9E79-F09857E7D866 Q36940607-4F4716C6-D30A-45F2-A27B-7D45985C182D Q36956716-B7F1D987-6BA9-4BED-ACCC-A03D55287984 Q37083073-72517AFB-92EA-4804-82B7-12703EEAEF99 Q37107283-05A03E32-8AB9-4E02-BDB0-2E143AD1B765 Q37156429-269BFA6A-0B32-4D7B-B5A7-F13790E9EFDD Q37231249-3844D236-0F93-485D-9633-9C3988ABCAC0 Q37299623-1461EA47-C48D-4CA7-BFA5-FFC98336EF96 Q37303275-93D7A709-9A8D-4897-86FA-3E2494D676C6 Q37625516-E3BA2A2B-8501-43A4-A56D-5D046AFB1257 Q38011774-DF0AD343-3002-45CC-B6F6-82B1D2D1418F Q38070133-A2A61CC8-40C3-4A58-97A2-7D5B7DBD7A97 Q38266870-955C361C-98B1-4FE8-B65C-47EAADBD5485 Q38423384-E0B8A419-0745-48C0-87B6-5B2F760528F1 Q38542886-D8822039-3B64-4990-BB01-ED58D2FD0732 Q39488367-F0E0AFE8-0ABD-44E8-850C-E3D87F3D87A4 Q40971037-93FD4F4B-065F-49CA-AC5C-AC511E073E38 Q42034781-56ACDF3C-1A73-4EF2-B2EC-58FFE5AA3B9C Q42046835-14897E55-BAA4-4F4F-83A8-0C3D10C37DE7 Q43473580-8AE3C00C-9EA8-4201-9273-BD94BCAD8CD7 Q43870068-ADEB055F-8F01-4F17-B1B2-A4377CA63BDC Q53083216-65E115EF-725F-46F7-A56E-52D50D86D95B

P2860

Therapeutic application of caspase 1/interleukin-1beta-converting enzyme inhibitor decreases the death rate in severe acute experimental pancreatitis

http://www.wikidata.org/entity/Q28344080

description

2002 nî lūn-bûn

@nan

2002 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Therapeutic application of cas ...... cute experimental pancreatitis

@ast

Therapeutic application of cas ...... cute experimental pancreatitis

@en

Therapeutic application of cas ...... cute experimental pancreatitis

@nl

type

label

Therapeutic application of cas ...... cute experimental pancreatitis

@ast

Therapeutic application of cas ...... cute experimental pancreatitis

@en

Therapeutic application of cas ...... cute experimental pancreatitis

@nl

prefLabel

Therapeutic application of cas ...... cute experimental pancreatitis

@ast

Therapeutic application of cas ...... cute experimental pancreatitis

@en

Therapeutic application of cas ...... cute experimental pancreatitis

@nl

P1433

Q28344080-31CD7291-6E2F-4839-96BE-7CFE1354451D

P1476

Q28344080-FCE97345-D93D-4170-9277-BA35A9B1CE02

P2093

Q28344080-06AFE6FB-EC15-4DCD-902E-8AA40300E658

Q28344080-20A4B336-7406-4DBE-9448-29AC8C32620A

Q28344080-2B21AD98-8A23-4906-AB1A-8BC67678B0AD

Q28344080-D8780DD1-0C6C-49B5-BF0E-25E0EA0F47A7

Q28344080-FF1F3D27-0518-44F2-A20E-207FB21F2BAD

P2860

Q28344080-0C4C173E-943D-4F8C-81EA-D621B3AF684A

Q28344080-0E77149A-6E43-4105-A78E-ABBA0C4E3772

Q28344080-118A4930-2BCC-4F6F-A316-C66778EEFDBD

Q28344080-1E615F64-63F2-4770-A983-83CC50658660

Q28344080-2348BD31-B0ED-4311-B2AF-93026F45943A

Q28344080-3129B39B-A961-4C4E-B8EA-B076D208B67F

Q28344080-38095BE1-16FF-4B80-81E3-B9DDECC2C7A5

Q28344080-3A28F527-B083-456F-AD03-E1DB42E47FFC

Q28344080-4CB29D54-5B46-4D70-BA5A-6D3CF2950B08

Q28344080-509C4AE2-C79E-4992-9E4D-33E1F9B1975B

P304

Q28344080-4F4584ED-91D0-4E72-ADBD-F0A17846AB04

P31

Q28344080-AFEB1F88-5EEF-47FB-9F84-412A253F32FE

P3181

Q28344080-40273E09-759C-409A-858A-075C4CC5CD2C

P356

Q28344080-EFB07D2E-5797-42A9-83A2-EE548B87AE23

P407

Q28344080-6D7315EE-6844-4BF1-BEA0-5E048141C81C

P433

Q28344080-1122F46C-39A0-40ED-9BE9-51BA20F4B580

P478

Q28344080-20ADEB87-BDC3-45D8-954B-7F459F256294

P577

Q28344080-EF54427F-0764-43FD-B0AD-94021FF56CB8

P5875

Q28344080-13C2F6C4-5DFB-4086-915C-97A1492BE643

P698

Q28344080-D13C25A7-04BB-48A7-AB52-9DAE14460E33

P921

Q28344080-9d0544f8-007d-4093-975f-f12026c70f55

P932

Q28344080-6986C782-AD4E-49C0-A8A7-B3EFE5E4550F

P3181

P356

00000658-200201000-00009

P1433

Annals of Surgery

P1476

Therapeutic application of cas ...... cute experimental pancreatitis

@en

P2093

Adam S Paszkowski

http://www.w3.org/2001/XMLSchema#string

Bettina Rau

http://www.w3.org/2001/XMLSchema#string

Hans G Beger

http://www.w3.org/2001/XMLSchema#string

Jens M Mayer

http://www.w3.org/2001/XMLSchema#string

Peter Möller

http://www.w3.org/2001/XMLSchema#string

P2860

Protein measurement with the Folin phenol reagent

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction

Structure and mechanism of interleukin-1 beta converting enzyme

Altered cytokine export and apoptosis in mice deficient in interleukin-1 beta converting enzyme

Mice deficient in IL-1 beta-converting enzyme are defective in production of mature IL-1 beta and resistant to endotoxic shock

Treatment of sepsis: past and future avenues.

Diagnosis, objective assessment of severity, and management of acute pancreatitis. Santorini consensus conference.

Bacterial infection and extent of necrosis are determinants of organ failure in patients with acute necrotizing pancreatitis.

Identification of a monocyte specific pre-interleukin 1 beta convertase activity.

Inflammatory mediators in human acute pancreatitis: clinical and pathophysiological implications.

P304

68-76

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1243560

http://www.w3.org/2001/XMLSchema#string

P356

10.1097/00000658-200201000-00009

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

235

http://www.w3.org/2001/XMLSchema#string

P577

2002-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11604420

http://www.w3.org/2001/XMLSchema#string

P698

11753044

http://www.w3.org/2001/XMLSchema#string

P921

P932

1422397

http://www.w3.org/2001/XMLSchema#string